Skip to content

Clinical trials

Completed Phase 2/3 trials in Saudi Arabia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 2/3 Status: Completed Country / region: Saudi Arabia Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20102
20141
20162
20181
20194
20203

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Beni-Suef University3
King Abdullah International Medical Research Center2
King Saud University2
Saudi German Hospital - Madinah2
Alexion Pharmaceuticals, Inc.1
McMaster University1
NRG Oncology1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
COVID-192
Polycystic Ovary Syndrome2
Anemia, Sickle Cell1
Bone Diseases1
Breast Neoplasms1
Chronic Periodontitis1
Diabetes Mellitus, Type 21
Hypophosphatasia1
Immunologic Deficiency Syndromes1
Iron Overload1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.